Begin main content

Optimal Use of Minimally Invasive Glaucoma Surgery: A Health Technology Assessment

Published on: December 3, 2018
Project Number: OP0532-000
Product Line: Optimal Use
Result type: Report
Expected Completion Date: March 20, 2019

Glaucoma is a leading cause of blindness. A range of surgical interventions exist for treating glaucoma, including a group of procedures commonly called micro-invasive or minimally invasive glaucoma surgery (MIGS). It has been noted that, across Canada, there is a growing demand for MIGS, as well as a rise in the use of MIGS procedures. At the same time, the cost of MIGS implantable devices can be considerable and inconsistencies appear to exist in some jurisdictions regarding coverage under public health insurance plans.

CADTH, in collaboration with Health Quality Ontario, undertook an Optimal Use project to assess the clinical effectiveness, safety, cost-effectiveness, patient perspectives and experiences, ethical issues, and implementation issues around MIGS devices and procedures for adults with glaucoma. 

Tags

eye, filtering surgery, glaucoma, glaucoma drainage implants, microsurgery, minimally invasive surgical procedures, ophthalmologic surgical procedures, ophthalmology, sclerostomy, stents, trabeculectomy, medical devices, surgery, Antiglaucoma, MIGS, Minimally Invasive, OAG, POAG, Stent, eyes, micro, ocular, shunt, shunts